Medicare Enrolled
Dr. Raghav Govindarajan, MD
Neurology · O Fallon, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Govindarajan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Govindarajan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Govindarajan
Dr. Raghav Govindarajan is a neurology specialist in O Fallon, IL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Govindarajan performed 36,966 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Govindarajan received a total of $695,543 from 34 pharmaceutical and/or device companies across 828 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Govindarajan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 1% volume in IL
$695,543 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗36,966
Medicare services
Top 1% in IL for neurology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
34,620 | $5 | $26 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
367 | $66 | $158 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
284 | $75 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
237 | $121 | $321 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 185 | $58 | $135 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
172 | $1 | $7 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
144 | $132 | $555 |
| Chemical nerve paralysis injection, each additional extremity Injection of a chemical agent to paralyze nerves and muscles in an additional arm or leg. This is billed for each extremity beyond the first one treated. |
122 | $100 | $394 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
116 | $65 | $781 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
111 | $130 | $376 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
110 | $220 | $569 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $93 | $228 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
81 | $44 | $636 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
57 | $131 | $440 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
47 | $106 | $265 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
46 | $28 | $124 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
45 | $171 | $437 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
43 | $42 | $203 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
28 | $67 | $198 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $129 | $320 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
16 | $183 | $508 |
| New patient office visit, complex (60-74 min) | 12 | $151 | $398 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$695,543
Total received (2018-2024)
Avg $99,363/year across 7 years
Top 1% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
828
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$149,709
2023
$161,667
2022
$92,985
2021
$114,198
2020
$58,038
2019
$80,548
2018
$38,400
Payments by company (2024)
ARGENX US, INC.
$47,948
UCB, Inc.
$25,994
Takeda Pharmaceuticals U.S.A., Inc.
$23,101
ABBVIE INC.
$22,309
Alexion Pharmaceuticals, Inc.
$14,283
Amgen Inc.
$12,101
Johnson & Johnson Health Care Systems Inc.
$2,725
Janssen Scientific Affairs, LLC
$1,000
PFIZER INC.
$248
Top 3 companies account for 64.8% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$243,325
ARGENX US, INC.
$115,233
Biohaven Pharmaceuticals, Inc.
$66,505
UCB, Inc.
$64,159
ABBVIE INC.
$52,039
Takeda Pharmaceuticals U.S.A., Inc.
$34,462
Biohaven Pharmaceutical Holding Company Ltd.
$28,955
Janssen Scientific Affairs, LLC
$20,795
Mitsubishi Tanabe Pharma America, Inc.
$15,284
Amgen Inc.
$12,101
F. Hoffmann-La Roche AG
$9,534
Janssen Global Services, LLC
$9,474
MITSUBISHI TANABE PHARMA AMERICA, INC.
$8,688
Sarepta Therapeutics, Inc.
$2,960
Johnson & Johnson Health Care Systems Inc.
$2,725
Biogen, Inc.
$1,850
AbbVie Inc.
$1,731
Amicus Therapeutics, Inc.
$1,600
Akcea Therapeutics, Inc.
$1,540
CATALYST PHARMACEUTICALS, INC.
$1,228
PFIZER INC.
$450
GENZYME CORPORATION
$159
CSL Behring
$122
Allergan, Inc.
$115
AbbVie, Inc.
$106
Medtronic USA, Inc.
$80
Medtronic, Inc.
$63
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$60
Sunovion Pharmaceuticals Inc.
$49
Genentech, Inc.
$48
Novartis Pharmaceuticals Corporation
$33
E.R. Squibb & Sons, L.L.C.
$30
Merz Pharmaceuticals, LLC
$25
Baxter Healthcare
$14
Top 3 companies account for 61.1% of all-time payments
Associated products mentioned in payments ›
ACTIVA · APTIOM · AUBAGIO · BOTOX · COMIRNATY · DUOPA · Duopa · ENSPRYNG · EXSERVAN · Enspryng · Evrysdi · FIRDAPSE · HYQVIA · Hillrom - Synclara Cough System · Hizentra · INTELLIS · KESIMPTA · LINQ II · MAYZENT · NURTEC ODT · Non-Covered Product · OCTAGAM IMMUNE GLOBULIN (HUMAN) · PANZYGA · PAXLOVID · QULIPTA · RADICAVA · Radicava · Rystiggo · SOLIRIS · Soliris · TEGSEDI · UBRELVY · ULTOMIRIS · UPLIZNA · Ultomiris · VYVGART · VYVGART HYTRULO · Xeomin · ZEPOSIA · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
223
County median income
$70,178
Nearest hospital to ZIP centroid (approximate)
HSHS ST ELIZABETH'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Govindarajan is a mixed practice specialist, with above-average Medicare volume (top 1% in IL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Govindarajan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Govindarajan performed 34,620 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Govindarajan receive payments from pharmaceutical companies?
Yes. Dr. Govindarajan received a total of $695,543 from 34 companies across 828 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Govindarajan's costs compare to other neurologists in O Fallon?
Dr. Govindarajan's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Govindarajan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in O Fallon
Browse neurologists in O Fallon ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in IL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in IL
Which IL neurologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
ARGENX US, INC. Payments to Doctors
See all physicians who received payments from ARGENX US, INC.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology